Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Helen Millns, PhD

GSK, Stevenage, UK, United Kingdom

Disclosure(s): GSK: Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-1492) Patient Characteristics Associated with Extended-Spectrum Beta-Lactamase-Producing Uropathogens: Pooled Results from Two Phase 3 Clinical Trials of Gepotidacin for the Treatment of Uncomplicated Urinary Tract Infection

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-1546) Discordant Clinical and Microbiological Responses are Associated with Late Clinical Relapse in Uncomplicated Urinary Tract Infections: Pooled Analysis of EAGLE-2/EAGLE-3 Trial Data

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT